Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | IGF1R | P08069 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | AGXT | P21549 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24915901 | 0.94 | KMT2A (0.47) | MEN1KMT2ACYP2A6CYP1A2TAAR1 | |
| SCHEMBL8764230 | 0.87 | MEN1 (0.64) | MEN1KMT2ACYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL7020238 | 0.84 | FFAR1 (0.66) | ALDH1A1FFAR1TDP1 | |
| SCHEMBL8505731 | 0.83 | IGF1R (0.47) | CYP2A6CYP1A2TAAR1ALDH1A1KCNH2 | |
| SCHEMBL9788917 | 0.81 | MEN1 (0.52) | MEN1KMT2ACYP2A6ALDH1A1MMP9 | |
| SCHEMBL10264572 | 0.81 | CYP2A6 (0.54) | MEN1KMT2ACYP2A6TAAR1SMN1; SMN2 | |
| SCHEMBL9552869 | 0.80 | KMT2A (0.56) | MEN1KMT2AALDH1A1HRH3FFAR1 | |
| SCHEMBL8763175 | 0.80 | MEN1 (0.56) | MEN1KMT2ACYP1A2ALDH1A1KCNH2 | |
| SCHEMBL23649655 | 0.78 | L3MBTL1 (0.43) | MEN1KMT2AALDH1A1MMP9MMP13 | |
| SCHEMBL31324214 | 0.77 | HSD17B10 (0.50) | MEN1KMT2ASMN1; SMN2ALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102300550-A | Perfume systems | — | 2011-12-28 | — | — | CN | claimed |
| EP-4737544-A1 | PERFUME COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025004871-A1 | PERFUME COMPOSITION | 三菱瓦斯化学株式会社 | 2025-01-02 | — | — | WO | disclosed |
| WO-2024008680-A1 | AZETIDINE DERIVATIVES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-01-11 | — | — | WO | disclosed |
| US-20230285378-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2023-09-14 | — | — | US | disclosed |
| US-11584736-B2 | Heterocyclic P2Y14 receptor antagonists | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-02-21 | — | — | US | disclosed |
| CN-110845364-B | Preparation method of nitrile compound with formamide as cyanogen source | 湘潭大学 | 2023-02-03 | — | — | CN | disclosed |
| EP-4116307-A1 | BORON CARRYING AGENT FOR INTEGRATED TUMOR DIAGNOSIS AND TREATMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Peking University (CN) | 2023-01-11 | — | — | EP | disclosed |
| CN-115403533-A | 1-styryl-1, 2, 3-triazole compound and preparation method and application thereof | 永康市第一人民医院 | 2022-11-29 | — | — | CN | disclosed |
| US-20210047293-A1 | HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-02-18 | — | — | US | disclosed |
| CN-1845901-A | CCK-1 receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2006-10-11 | — | — | CN | disclosed |
| CN-1678587-A | CCK-1 receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2005-10-05 | — | — | CN | disclosed |
| CN-1138756-C | Preparation of tirt nitrile substituted aromatic compound | �Ʒ� | 2004-02-18 | — | — | CN | disclosed |
| CN-1271723-A | Preparation of tirt nitrile substituted aromatic compound | PFIZER PRODUCT CO (US) | 2000-11-01 | — | — | CN | disclosed |
| US-5214193-A | Coupling a dialkylphenol with aldehyde, esterification, crystallization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0270841-A2 | 2-Methyl-3-(para-methyl-phenyl) propionitrile, its preparation and use as a perfuming agent | BASF Aktiengesellschaft (DE) | 1988-06-15 | — | — | EP | disclosed |
| US-4536599-A | HYDROLYZING THE NITRILE DERIVATIVE TO THE AMIDE USING AN ORGANIC QUATERNARY AMINE SALT CATALYST; EFFICIENCY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-08-20 | — | — | US | disclosed |
| EP-0040896-B1 | SYNTHESIS OF AMIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-04-25 | — | — | EP | disclosed |
| EP-0040896-A2 | Synthesis of amides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-12-02 | — | — | EP | disclosed |
| EP-0008532-A1 | Synthesis of amines | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584736-B2 | Heterocyclic P2Y14 receptor antagonists | P2RY14, P2RY1, P2RY13 | MEN1 3092/4885KMT2A 3831/4885CYP2A6 2337/4885 |
| US-20230285378-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | MEN1 4681/4885KMT2A 4093/4885CYP2A6 2582/4885 |
| US-20210047293-A1 | HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | P2RY14, P2RY1, P2RY13 | MEN1 3092/4885KMT2A 3831/4885CYP2A6 2337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.